Looking after our health and getting medical treatment when we need it is our own responsibility, like getting food, clothes and shelter, and should not be the business of the government. Now medical research finds that treatment for many diseases needs to be  tailor-made for individuals, and ethnicity and gender can make a difference.

Peter W Huber writes (read his whole article here):

No privacy-protecting, discrimination-banning law, no promise that someone else will pay, will ensure that a drug that suits others will suit your genetic profile too… 

This is where diversity blather gives way to the rigorous diversity science that’s taking over the medical show. Drugs supply almost all the real health care these days, because human hands are too big to grapple with the microscopic things that cause most of our problems. Eugenic drugs reflect how biochemically separate and unequal people are. Some, indeed, target genes that track sex, race, or ethnicity; their FDA licenses affirm truths unmentionable in polite society and approve conduct illegal in every other sphere of commerce and public life. All are terrible news for anyone determined to pull people together, pool medicine’s costs, equalize its benefits, and lose diversity in the crowd. The doctors of equity promise universal access to the Mayo Clinic, where the real doctors now brew discriminatory cures and card your genes at the door…

The patient’s chemistry matters as much as the drug’s. Americans are biochemically diverse. Only so much can be learned at the Mayo Clinic; the rest has to be learned from patients whose chemistries weren’t invited to the trial. Trying to invite them all leads to quagmire and stifles learning before it begins. Getting from where we are now to universal care at the pharmacy will involve far more information than Washington can ever hope to assimilate.